erlotinib
Ligand Summary
A quinazoline derivative and ANTINEOPLASTIC AGENT that functions as a PROTEIN KINASE INHIBITOR for EGFR associated tyrosine kinase. It is used in the treatment of NON-SMALL CELL LUNG CANCER.
UNII: J4T82NDH7E
PubChem: 176870
PubChem: 44263854
Guide to Pharmacology: 4920
ChEMBL: CHEMBL553
ChEMBL: CHEMBL1079742
DrugCentral: 1045
LyCHI: NUXHNF3XHDN6
Target Activities
111 Activities
Items per page:
1 – 10 of 111
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
Kd | ||||||
IC50 | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||
Ki | ||||||